Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vetnil is a prominent Brazilian veterinary pharmaceutical company dedicated to the development and commercialization of health and nutrition products for animals. Established in 1994 by Dr. João Carlos Ribeiro, the company has become a market leader in the equine segment and maintains a strong presence in the pet and livestock sectors. Its portfolio includes a diverse range of medications, supplements, and hygiene products manufactured at its state-of-the-art facility in Louveira, São Paulo. Vetnil is recognized for its commitment to innovation and quality, exporting its veterinary solutions to over 15 countries across Latin America, the Middle East, and Europe. The company is frequently awarded for its business excellence and is considered one of the most influential players in the South American animal health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vetnil.